Zobrazeno 1 - 10
of 214
pro vyhledávání: '"Pieter, Vermeersch"'
Autor:
Casper Vrij, Kris Bogaerts, Pieter Vermeersch, Katrien Lagrou, Geert Molenberghs, Filip Rega, Laurens J. Ceulemans, Dirk Van Raemdonck, Ina Jochmans, Diethard Monbaliu, Jacques Pirenne, Geert Robaeys, Bart De Moor, Tim Vanuytsel, Pieter Gillard, Hélène Schoemans, Johan Van Cleemput, Dirk Kuypers, Robin Vos, Frederik Nevens, Jef Verbeek
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The role of immunosuppressive therapy on SARS-CoV-2 infection risk and COVID-19 severity remains unclear in unvaccinated solid organ transplant recipients. We included 1957 organ transplant recipients between July 2020 and April 2021 to anal
Externí odkaz:
https://doaj.org/article/e4db65781cdd4bf3a059ce81a379c86b
Autor:
Andrew Holtz, Johan Van Weyenbergh, Samuel L. Hong, Lize Cuypers, Áine O’Toole, Gytis Dudas, Marco Gerdol, Barney I. Potter, Francine Ntoumi, Claujens Chastel Mfoutou Mapanguy, Bert Vanmechelen, Tony Wawina-Bokalanga, Bram Van Holm, Soraya Maria Menezes, Katja Soubotko, Gijs Van Pottelbergh, Elke Wollants, Pieter Vermeersch, Ann-Sophie Jacob, Brigitte Maes, Dagmar Obbels, Veerle Matheeussen, Geert Martens, Jérémie Gras, Bruno Verhasselt, Wim Laffut, Carl Vael, Truus Goegebuer, Rob van der Kant, Frederic Rousseau, Joost Schymkowitz, Luis Serrano, Javier Delgado, Tom Wenseleers, Vincent Bours, Emmanuel André, Marc A. Suchard, Andrew Rambaut, Simon Dellicour, Piet Maes, Keith Durkin, Guy Baele
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-18 (2024)
Abstract We investigate the emergence, mutation profile, and dissemination of SARS-CoV-2 lineage B.1.214.2, first identified in Belgium in January 2021. This variant, featuring a 3-amino acid insertion in the spike protein similar to the Omicron vari
Externí odkaz:
https://doaj.org/article/e0f6914f63ac463b94c41b5682afba1e
Autor:
Glynis Frans, Doreen Dillaerts, Tom Dehaemers, Jan Van Elslande, Jonas De Leeuw, Lise Boon, Wim Maes, Nico Callewaert, Bas Calcoen, Lina Ancheva, Maaike Cockx, Nick Geukens, Kusay Arat, Rita Derua, Pieter Vermeersch, Sebastien Christian Carpentier, Xavier Bossuyt
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Pre-vaccination SARS-CoV-2 infection can boost protection elicited by COVID-19 vaccination and post-vaccination breakthrough SARS-CoV-2 infection can boost existing immunity conferred by COVID-19 vaccination. Such ‘hybrid immunity’ is effective a
Externí odkaz:
https://doaj.org/article/128c3bf6fa72485fa13dcf0c22736c77
Autor:
Bram Decru, Jan Van Elslande, Sophie Steels, Gijs Van Pottelbergh, Lode Godderis, Bram Van Holm, Xavier Bossuyt, Johan Van Weyenbergh, Piet Maes, Pieter Vermeersch
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/650ddf1eac604ea1a092fb78a2c53bdb
Autor:
Isabelle Adant, Matthew Bird, Bram Decru, Petra Windmolders, Marie Wallays, Peter de Witte, Daisy Rymen, Peter Witters, Pieter Vermeersch, David Cassiman, Bart Ghesquière
Publikováno v:
Molecular Metabolism, Vol 63, Iss , Pp 101537- (2022)
Introduction: Primary mitochondrial diseases (PMD) are a large, heterogeneous group of genetic disorders affecting mitochondrial function, mostly by disrupting the oxidative phosphorylation (OXPHOS) system. Understanding the cellular metabolic re-wir
Externí odkaz:
https://doaj.org/article/7ed8e9ba5937483b8ad271db0b82cab8
Autor:
Majdouline El Moussaoui, Salomé Desmecht, Nicolas Lambert, Nathalie Maes, Joachim Braghini, Nicole Marechal, Céline Quintana, Karine Briquet, Stéphanie Gofflot, Françoise Toussaint, Marie-Pierre Hayette, Pieter Vermeersch, Laurence Lutteri, Céline Grégoire, Yves Beguin, Souad Rahmouni, Michel Moutschen, Daniel Desmecht, Gilles Darcis
Publikováno v:
Viruses, Vol 15, Iss 7, p 1435 (2023)
(1) Background: Many vaccines require higher, additional doses or adjuvants to provide adequate protection for people living with HIV (PLWH). Despite their potential risk of severe coronavirus disease 2019, immunological data remain sparse, and a cle
Externí odkaz:
https://doaj.org/article/a65070abb62e42c392ccdbaf3aa505de
Autor:
Beatrijs Mertens, Omar Elkayal, Erwin Dreesen, Joost Wauters, Philippe Meersseman, Yves Debaveye, Karlien Degezelle, Pieter Vermeersch, Matthias Gijsen, Isabel Spriet
Publikováno v:
Antibiotics, Vol 12, Iss 7, p 1085 (2023)
Effective dosing of isavuconazole in patients supported by extracorporeal membrane oxygenation (ECMO) is important due to the role of isavuconazole as a first-line treatment in patients with influenza- and COVID-19-associated pulmonary aspergillosis.
Externí odkaz:
https://doaj.org/article/5e018632c9594518818a8b0aab66baaa
Autor:
Nathalie M. Vandevelde, Pieter Vermeersch, Katrien M. J. Devreese, Marie-Françoise Vincent, Béatrice Gulbis, François Eyskens, François Boemer, André Gothot, Viviane O. Van Hoof, Carolien Bonroy, Hedwig Stepman, Geert A. Martens, Xavier Bossuyt, Laurence Roosens, Julie Smet, Hilde Laeremans, Ilse Weets, Jean-Marc Minon, Kris Vernelen, Wim Coucke, Advisory Board of the Action 1 of the Belgian National Plan for Rare Diseases
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-16 (2021)
Abstract Background One objective of the Belgian Rare Diseases plan is to improve patients’ management using phenotypic tests and, more specifically, the access to those tests by identifying the biochemical analyses used for rare diseases, developi
Externí odkaz:
https://doaj.org/article/2dc4256c7b404443ba1a0495f3f1c794
Autor:
Bram Decru, Jan Van Elslande, Sophie Steels, Gijs Van Pottelbergh, Lode Godderis, Bram Van Holm, Xavier Bossuyt, Johan Van Weyenbergh, Piet Maes, Pieter Vermeersch
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundIgG anti-spike (S) antibodies arise after SARS-CoV-2 infection as well as vaccination. Levels of IgG anti-S are linked to neutralizing antibody titers and protection against (re)infection.MethodsWe measured IgG anti-S and surrogate neutrali
Externí odkaz:
https://doaj.org/article/b8b695148afd4e81ba982eabb6625293
Autor:
Salomé Desmecht, Aleksandr Tashkeev, Majdouline El Moussaoui, Nicole Marechal, Hélène Perée, Yumie Tokunaga, Celine Fombellida-Lopez, Barbara Polese, Céline Legrand, Marie Wéry, Myriam Mni, Nicolas Fouillien, Françoise Toussaint, Laurent Gillet, Fabrice Bureau, Laurence Lutteri, Marie-Pierre Hayette, Michel Moutschen, Christelle Meuris, Pieter Vermeersch, Daniel Desmecht, Souad Rahmouni, Gilles Darcis
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundUnderstanding and measuring the individual level of immune protection and its persistence at both humoral and cellular levels after SARS-CoV-2 vaccination is mandatory for the management of the vaccination booster campaign. Our prospective
Externí odkaz:
https://doaj.org/article/ce1d811b41dc47c2b72925b49ef000d2